Trials / Unknown
UnknownNCT04475042
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction. A 35-week, Single-center, Prospective, Double-blind, Controlled, Randomized, 2x2 Crossover, Interventional Phase II Study, Investigating the Effect of Treatment With Dapagliflozin 10mg od on Left Ventricular Distensibility in Patients With Early HFpEF.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Mariëlle Scheffer · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A 35-week, single-center, prospective, double-blind, controlled, randomized, 2x2 crossover, interventional Phase II study, investigating the effect of treatment with dapagliflozin 10mg od on Left Ventricular distensibility in patients with early HFpEF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapagliflozin | 10mg od |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-11-01
- Completion
- 2022-05-01
- First posted
- 2020-07-17
- Last updated
- 2020-09-22
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04475042. Inclusion in this directory is not an endorsement.